Braidwell LP Boosts Holdings in Danaher Corporation $DHR

Braidwell LP raised its holdings in Danaher Corporation (NYSE:DHR) by 8.1% during the 2nd quarter, Holdings Channel reports. The firm owned 150,627 shares of the conglomerate’s stock after purchasing an additional 11,300 shares during the quarter. Braidwell LP’s holdings in Danaher were worth $28,691,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Danaher during the 2nd quarter worth approximately $10,492,520,000. State Street Corp lifted its stake in Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after buying an additional 472,608 shares in the last quarter. Capital International Investors grew its holdings in Danaher by 8.9% during the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after buying an additional 1,487,768 shares during the last quarter. Wellington Management Group LLP grew its holdings in Danaher by 10.4% during the 2nd quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after buying an additional 1,542,310 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in Danaher by 9.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after buying an additional 1,334,221 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

DHR stock opened at $210.07 on Thursday. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The stock’s fifty day simple moving average is $201.15 and its 200-day simple moving average is $192.19. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $147.68 billion, a price-to-earnings ratio of 37.31, a price-to-earnings-growth ratio of 2.58 and a beta of 0.78.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the firm posted $0.77 earnings per share. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. Equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Ratings Changes

DHR has been the subject of a number of analyst reports. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a report on Monday, June 1st. Piper Sandler began coverage on Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. Stifel Nicolaus cut their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 target price on shares of Danaher in a report on Wednesday, July 22nd. Finally, HSBC decreased their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.